Bioprocess Bags Market size is poised to reach USD 23 Billion by the end of 2036, growing at a CAGR of 19% during the forecast period, i.e., 2024-2036. In the year 2023, the industry size of bioprocess bags was USD 5 Billion. The reason behind the growth is impelled by the spiking manufacturing of vaccines. Pharmaceutical firms create and make use of bioprocess to develop, transport, are cultivate vaccines.
Lately, more than 1 billion doses of vaccine are produced globally each month, and the total vaccine production exceeded the global demand in 2022 to over 22 billion.
The growing popularity of single-use bioprocessing technologies are believed to fuel the bioprocess bags market. Owing to the quick uptake of disposable bioprocessing equipment by pharmaceutical firms, single-use technologies, or goods meant for one-time use, have acquired substantial popularity that can be employed throughout the bioproduction process, from the creation of buffers and media to the cultivation of vaccines in bioreactors.
|
Base Year |
2023 |
|
Forecast Year |
2024-2036 |
|
CAGR |
~19% |
|
Base Year Market Size (2023) |
~ USD 5 Billion |
|
Forecast Year Market Size (2036) |
~ USD 23 Billion |
|
Regional Scope |
|
Growth Drivers
Challenges
Type (2D Bioprocess Bags, 3D Bioprocess Bags)
The 2D bioprocess bags segment in the bioprocess bags market is estimated to gain a robust revenue share of 56% in the coming years owing to the rising prevalence of diabetes. Compared to high-income countries, prevalence has been increasing more quickly in low- and middle-income nations as a result of an increase in obesity, alcohol consumption, immigration, and urbanization brought on by a variety of factors which is a significant factor in kidney failure, heart attacks, strokes, blindness, and lower limb amputating.
Diabetes treatment frequently includes taking insulin or other diabetes medications or the use of an insulin pump, routine blood sugar monitoring, and carbohydrate tracking by frequently utilizing a variety of insulin kinds that differ in their rates of action and the duration of their effects as it takes the place of the hormone that your body is unable to make.
Moreover, 2D bioprocess bags are used for a wide range of uses including the preparation, storage, and transportation of biopharmaceutical solutions such as insulin and other diabetes-related solutions. By 2030, there will be more than 7070 new cases of type 2 diabetes worldwide for every 100,000 people.
Bioprocess bags market from the 3D bioprocess bags segment is anticipated to garner notable revenue share during the forecast timeframe. The 3D single-use bag comes in sizes ranging from 50L to 3.500L and has a completely inert polyethylene fluid contact layer created from different films that each have special qualities that are the perfect option for a variety of biopharmaceutical applications, including the preparation, storage, and transportation of biopharmaceutical solutions.
Workflow (Upstream Process, Downstream Process, Process Development)
The upstream process segment is expected to hold 44% share of the global bioprocess bags market during the forecast period. Cell cultures, medium, and other biopharmaceutical production materials are stored and transported using bioprocessing bags in upstream processing to reduce the danger of contamination and are essential for preserving the effectiveness and safety of biopharmaceutical products. Furthermore, the downstream process may gain a significant share as they provide a number of benefits, such as a lower risk of contamination, less cleaning and validation procedures.
End-User (Pharmaceutical & Biopharmaceutical Companies, CMOs & CROs, Academic & Research Institutes)
The pharmaceutical & biopharmaceutical companies segment is poised to account for 47% of the global bioprocess bags market share by 2036, due to the rising introduction of new products. For instance, in February 2021, Saint-Gobain Life Sciences, a pioneer in the production of innovative, high-performance polymer solutions launched a new cell VueLife "HP" Series Bag cell culture testing culture bag designed specifically for T cell-derived therapies with a unique laminate film layer for treating cancer by harnessing the patient’s immune system by isolating their T cells and engineering them to elicit an immune response.
Our in-depth analysis of the global bioprocess bags market includes the following segments:
|
Type |
|
|
Workflow |
|
|
Application |
|
|
End-User |
|
|
Product |
|
|
Capacity |
|
North American Market Forecast
Bioprocess bags market in North America is predicted to account for the largest share of 36% by 2036 impelled by the rising funding in the manufacturing of vaccines. As a result, there has been an increase in the development of vaccines in the region which would lead to higher demand for bioprocess bags. For instance, As of April 2020, American biopharmaceutical companies worked on around 240 vaccines to prevent and treat diseases such as cancer, Alzheimer's disease, allergies, and autoimmune disorders by employing new technologies that have the potential to stop the spread of human immunodeficiency virus (HIV), provide protection against malaria, and treat various types of cancer. In 2020 through March 2022, the US federal government spent over USD 2 billion on research and development of the mRNA COVID-19 vaccines.
APAC Market Statistics
The APAC bioprocess bags market is estimated to be the second largest, during the forecast timeframe led by rapidly rising population. It is expected that a high birth rate, rapid industrialization and the expansion of opportunity in cities, lack of education, illiteracy, inadequate sex education knowledge, rituals, and superstition are the important factors in population growth in countries such as India, and China. These factors have led to increasing demand for various biopharmaceutical products including vaccines, drugs, and other related products. As a consequence, a huge demand for bioprocess bags can be witnessed in the region by the year 2036. According to estimates, the population of India is expected to reach over 1 billion by 2030.
Author Credits: Smruti Ranjan, Rajrani Baghel
FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.
Have questions before ordering this report?